Fresenius Medical Care Renal Therapies Group, LLC: FDA filings under this applicant name

FDA lists 53 510(k) clearances under the applicant name “Fresenius Medical Care Renal Therapies Group, LLC” (first 2013, latest 2026), across 10 product codes in 2 review panels. Median 510(k) review time under this name: 148 days. Since 2017 the median was 178 days, against 198 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under Fresenius Medical Care, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20131107
2014290
20151266
2016288
20173141
20186111
20192155
20207268
20210—
20225247
20234326
20244178
202511116
20265189

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Fresenius Medical Care Renal Therapies Group, LLC took a median 178 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 198 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
KDIDialyzer, High Permeability With Or Without Sealed Dialysate System2020
KPODialysate Concentrate For Hemodialysis (Liquid Or Powder)1010
FKXSystem, Peritoneal, Automatic Delivery66
FIPSubsystem, Water Purification44
KDJSet, Administration, For Peritoneal Dialysis, Disposable44
KOCAccessories, Blood Circuit, Hemodialysis44
QJZExtracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure22
DSBPlethysmograph, Impedance11
FJIDialyzer, Capillary, Hollow Fiber11
FJKSet, Tubing, Blood, With And Without Anti-Regurgitation Valve11

Review panels

Most recent Fresenius Medical Care Renal Therapies Group, LLC 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K261203multiFiltratePRO SystemKDI2026-10-19189
K261267Careflux H60;Careflux H70;Careflux V500KDI2026-07-2499
K252377NxStage System One with NxViewKDI2026-05-15289
K252459multiFlux 130 (F00013123); multiFlux 160 (F00013124)KDI2026-02-10189
K253462NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)KPO2026-01-29114
K253518FX CorAL 40; FX CorAL 50KDI2025-12-1836
K250634BCM2-Body Composition MonitorDSB2025-11-24266
K250471AquaC UNO HFIP2025-11-14269
K251851DIASAFEplusUS (F00013010)FIP2025-10-09115
K252180Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby Dialysate RFP-403 (RFP-403-G); Bicarby Dialysate RFP-453 (RFP-453-W); Bicarby Dialysate RFP-453 (RFP-453-G); Bicarby Dialysate RFP-454 (RFP-454-W); Bicarby Dialysate RFP-454 (RFP-454-G); Bicarby Dialysate RFP-456 (RFP-456-W)KPO2025-09-0960

43 earlier clearances. See the full list in Caduvo.

Recalls

34 product recalls in 21 recall events; 9 initiated in the last five years. Most recent: 2026-08-10.

38 product recalls in 17 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 28 initiated in the last five years. Most often: Fresenius Medical Care Holdings, Inc. (38).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Parent company SEC filings

Fresenius Medical Care AG (FMCQF, FMS): EDGAR filings, CIK 1333141. Caduvo groups Fresenius Medical Care Renal Therapies Group, LLC under Fresenius Medical Care; the parent's SEC registrant is entered by hand for the group, not matched by name.

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Fresenius Medical Care Renal Therapies Group, LLC?

FDA lists 53 510(k) clearances under the applicant name “Fresenius Medical Care Renal Therapies Group, LLC” (first 2013, latest 2026), across 10 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Fresenius Medical Care Renal Therapies Group, LLC?

The median time from FDA receipt to decision across 510(k)s cleared under the name Fresenius Medical Care Renal Therapies Group, LLC is 148 days. Since 2017: 178 days, versus 198 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Fresenius Medical Care Renal Therapies Group, LLC?

The most frequent FDA product codes under this applicant name are KDI (Dialyzer, High Permeability With Or Without Sealed Dialysate System, 20); KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder), 10); FKX (System, Peritoneal, Automatic Delivery, 6).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup